Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans

Journal of Hepatology

Volumn 56, Issue 3, 2012, Pages 663-670

  Pihlajamäki, Jussi ^a,b   Kuulasmaa, Tiina ^a   Kaminska, Dorota ^a   Simonen, Marko ^a   Kärjä, Vesa ^b   Grönlund, Sari ^b   Käkelä, Pirjo ^b   Pääkkönen, Matti ^b   Kainulainen, Sakari ^b   Punnonen, Kari ^b   Kuusisto, Johanna ^a   Gylling, Helena ^b   Laakso, Markku ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cytokines; IL 1RA; Insulin resistance; Interleukin 1 receptor antagonist; Nonalcoholic steatohepatitis; Obesity; Population study; Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MESSENGER RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE EXPRESSION; HEPATITIS; HISTOLOGY; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

ADULT; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BIOPSY; FATTY LIVER; FEMALE; GENOTYPE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LIPASE; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OBESITY, MORBID; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84857355693     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.10.005     Document Type: Article

References (38)

1. L.A. Adams, and K.D. Lindor Nonalcoholic fatty liver disease Ann Epidemiol 17 2007 863 869
2. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 2011 274 285
3. J.D. Browning, and J.D. Horton Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 2004 147 152
4. M. Adiels, M.R. Taskinen, C. Packard, M.J. Caslake, A. Soro-Paavonen, and J. Westerbacka Overproduction of large VLDL particles is driven by increased liver fat content in man Diabetologia 49 2006 755 765
5. A. Kotronen, and H. Yki-Jarvinen Fatty liver. A novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 2008 27 38
6. K.M. Korenblat, E. Fabbrini, B.S. Mohammed, and S. Klein Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects Gastroenterology 134 2008 1369 1375
7. M. Ekstedt, L.E. Franzen, U.L. Mathiesen, L. Thorelius, M. Holmqvist, and G. Bodemar Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
8. A. Wieckowska, A.J. McCullough, and A.E. Feldstein Non-invasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future Hepatology 46 2007 582 589
9. A.K. Agarwal, and A. Garg Genetic disorders of adipose tissue development, differentiation, and death Annu Rev Genomics Hum Genet 7 2006 175 199
10. M. Perez-Carreras, P. Del Hoyo, M.A. Martin, J.C. Rubio, A. Martin, and G. Castellano Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis Hepatology 38 2003 999 1007
11. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, and R.K. Sterling Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192
12. M. Kohjima, M. Enjoji, N. Higuchi, M. Kato, K. Kotoh, and T. Yoshimoto Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease Int J Mol Med 20 2007 351 358
13. P. Puri, R.A. Baillie, M.M. Wiest, F. Mirshahi, J. Choudhury, and O. Cheung A lipidomic analysis of nonalcoholic fatty liver disease Hepatology 46 2007 1081 1090
14. B. Feve, and J.P. Bastard The role of interleukins in insulin resistance and type 2 diabetes mellitus Nat Rev Endocrinol 5 2009 305 311
15. A. Stancakova, M. Javorsky, T. Kuulasmaa, S.M. Haffner, J. Kuusisto, and M. Laakso Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6, 414 Finnish men Diabetes 58 2009 1212 1221
16. J. Pihlajamaki, S. Gronlund, M. Simonen, P. Kakela, L. Moilanen, and M. Paakkonen Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding Metabolism 59 2010 866 872
17. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470
18. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
19. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
20. D. Melzer, J.R. Perry, D. Hernandez, A.M. Corsi, K. Stevens, and I. Rafferty PLoS Genet 4 2008 e1000072
21. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
22. A. Kotronen, M. Peltonen, A. Hakkarainen, K. Sevastianova, R. Bergholm, and L.M. Johansson Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors Gastroenterology 137 2009 865 872
23. J.M. Hui, A. Hodge, G.C. Farrell, J.G. Kench, A. Kriketos, and J. George Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40 2004 46 54
24. J. Saltevo, M. Laakso, J. Jokelainen, S. Keinanen-Kiukaanniemi, E. Kumpusalo, and M. Vanhala Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: a population-based study Diabetes Metab Res Rev 24 2008 378 383
25. J. Petrasek, A. Dolganiuc, T. Csak, E.A. Kurt-Jones, and G. Szabo Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice Gastroenterology 140 2011 697 708 e694
26. R.Z. Zhu, D. Xiang, C. Xie, J.J. Li, J.J. Hu, and H.L. He Protective effect of recombinant human IL-1Ra on CCl4-induced acute liver injury in mice World J Gastroenterol 16 2010 2771 2779
27. O. Nov, A. Kohl, E.C. Lewis, N. Bashan, I. Dvir, and S. Ben-Shlomo Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation Endocrinology 151 2010 4247 4256
28. K. Isoda, S. Sawada, M. Ayaori, T. Matsuki, R. Horai, and Y. Kagata Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice J Biol Chem 280 2005 7002 7009
29. K.D. Sekiyama, M. Yoshiba, and A.W. Thomson Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis Clin Exp Immunol 98 1994 71 77
30. L. Gramantieri, A. Casali, D. Trere, S. Gaiani, F. Piscaglia, and P. Chieco Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis Clin Exp Immunol 115 1999 515 520
31. E. Somm, P. Cettour-Rose, C. Asensio, A. Charollais, M. Klein, and C. Theander-Carrillo Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents Diabetologia 49 2006 387 393
32. C.E. Juge-Aubry, E. Somm, V. Giusti, A. Pernin, R. Chicheportiche, and C. Verdumo Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation Diabetes 52 2003 1104 1110
33. J.N. Fain Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells Vitam Horm 74 2006 443 477
34. C.E. Juge-Aubry, E. Somm, R. Chicheportiche, D. Burger, A. Pernin, and B. Cuenod-Pittet Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue J Clin Endocrinol Metab 89 2004 2652 2658
35. E. Ruotsalainen, U. Salmenniemi, I. Vauhkonen, J. Pihlajamaki, K. Punnonen, and S. Kainulainen Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects Diabetes Care 29 2006 2714 2720
36. A. Wieckowska, and A.E. Feldstein Diagnosis of nonalcoholic fatty liver disease: invasive versus non-invasive Semin Liver Dis 28 2008 386 395
37. M.H. Jarrar, A. Baranova, R. Collantes, B. Ranard, M. Stepanova, and C. Bennett Adipokines and cytokines in non-alcoholic fatty liver disease Aliment Pharmacol Ther 27 2008 412 421
38. E. Zimmermann, R. Anty, J. Tordjman, A. Verrijken, P. Gual, and A. Tran C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients J Hepatol 55 2011 660 665